LU85034A1
(fr)
*
|
1982-10-08 |
1985-06-19 |
Glaxo Group Ltd |
Dispositifs en vue d'administrer des medicaments a des patients
|
SE453566B
(sv)
*
|
1986-03-07 |
1988-02-15 |
Draco Ab |
Anordning vid pulverinhalatorer
|
US4706663A
(en)
*
|
1986-04-25 |
1987-11-17 |
Makiej Paul A |
Particle catcher for inhalation devices
|
JPS63143081A
(ja)
*
|
1986-12-05 |
1988-06-15 |
メクト株式会社 |
吸入器
|
US5011044A
(en)
*
|
1987-07-02 |
1991-04-30 |
Brown Arlon R |
Anti-assault device
|
DE8714078U1
(da)
*
|
1987-10-21 |
1988-02-04 |
Schott, Kaete, 8651 Kupferberg, De |
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
TW197380B
(da)
*
|
1990-03-02 |
1993-01-01 |
Glaxo Group Ltd |
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
CN1119833A
(zh)
*
|
1993-03-03 |
1996-04-03 |
泰纳克斯公司 |
干粉吸入器的药粉载盘
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
US5699789A
(en)
*
|
1996-03-11 |
1997-12-23 |
Hendricks; Mark R. |
Dry powder inhaler
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
DE19835346A1
(de)
*
|
1998-08-05 |
2000-02-10 |
Boehringer Ingelheim Pharma |
Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
US6451289B2
(en)
|
2000-03-24 |
2002-09-17 |
Sepracor Inc. |
Albuterol formulations
|
US6596262B2
(en)
|
2001-02-15 |
2003-07-22 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
US6485707B2
(en)
|
2001-02-15 |
2002-11-26 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
ATE255929T1
(de)
*
|
2001-03-05 |
2003-12-15 |
Ivo Pera |
Inhalationsvorrichtung zum dispergieren von in kapseln enthaltenen pulverförmigen medikamente durch den respirationstrakt
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
EP1587482A4
(en)
*
|
2003-01-31 |
2010-08-25 |
Technion Res & Dev Foundation |
ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US7624733B2
(en)
*
|
2004-02-09 |
2009-12-01 |
Oriel Therapeutics, Inc. |
Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
DE102005001332A1
(de)
*
|
2005-01-11 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
HUE030419T2
(en)
|
2005-05-18 |
2017-05-29 |
Horizon Orphan Llc |
Aerosolized fluoroquinolones and their uses
|
EP1844805A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Inhalator
|
EP2247330B1
(en)
|
2008-02-07 |
2017-09-20 |
The University of Washington |
Circumferential aerosol device
|
AU2009226019C1
(en)
|
2008-03-20 |
2014-02-20 |
Virun, Inc. |
Emulsions including a PEG-derivative of tocopherol
|
US8765661B2
(en)
|
2008-03-20 |
2014-07-01 |
Virun, Inc. |
Compositions containing non-polar compounds
|
WO2010008475A2
(en)
*
|
2008-06-23 |
2010-01-21 |
Virun, Inc. |
Compositions containing nono-polar compounds
|
KR20110091510A
(ko)
|
2008-10-07 |
2011-08-11 |
엠펙스 파마슈티컬즈, 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
PL2346509T3
(pl)
|
2008-10-07 |
2021-03-08 |
Horizon Orphan Llc |
Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
|
CN102405044A
(zh)
|
2009-02-06 |
2012-04-04 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
AU2010273514B2
(en)
|
2009-07-15 |
2015-01-22 |
Theravance Biopharma R&D Ip, Llc |
Crystalline freebase forms of a biphenyl compound
|
SI2473170T1
(sl)
|
2009-09-04 |
2019-10-30 |
Horizon Orphan Llc |
Uporaba aerosoliziranega levofloksacina za zdravljenje cistične fibroze
|
US20110229437A1
(en)
*
|
2009-09-17 |
2011-09-22 |
Mutual Pharmaceutical Company, Inc. |
Method of Treating Asthma with Antiviral Agents
|
WO2011060334A2
(en)
|
2009-11-12 |
2011-05-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
US9320295B2
(en)
|
2010-03-23 |
2016-04-26 |
Virun, Inc. |
Compositions containing non-polar compounds
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
FR2962343B1
(fr)
*
|
2010-07-07 |
2012-08-03 |
Valois Sas |
Inhalateur de poudre seche.
|
FR2962341B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
FR2962342B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
CN103096958A
(zh)
*
|
2010-07-07 |
2013-05-08 |
阿普塔尔法国简易股份公司 |
干粉末吸入器使用方法
|
FR2962340B1
(fr)
*
|
2010-07-07 |
2012-08-03 |
Valois Sas |
Inhalateur de poudre seche.
|
FR2962337B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
ES2600928T3
(es)
|
2010-08-27 |
2017-02-13 |
Neonc Technologies Inc. |
Composiciones farmacéuticas que comprenden derivados de alcohol perilílico
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
WO2012083178A1
(en)
|
2010-12-17 |
2012-06-21 |
Neo Oncology Inc. |
Methods and devices for using isoperillyl alcohol
|
USD666096S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666099S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666492S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666493S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666098S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666097S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
EP2648788B1
(en)
|
2010-12-07 |
2017-08-09 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
AU2012212269B2
(en)
|
2011-01-31 |
2016-05-19 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
EP3679971B1
(en)
|
2011-03-03 |
2022-07-27 |
Impel Pharmaceuticals Inc. |
Nasal drug delivery device
|
EP3851142A1
(en)
|
2011-05-09 |
2021-07-21 |
Impel NeuroPharma Inc. |
Nozzles for nasal drug delivery
|
FR2977498B1
(fr)
*
|
2011-07-05 |
2015-10-02 |
Valois Sas |
Inhalateur de poudre seche.
|
EP2731572B1
(en)
|
2011-07-13 |
2021-04-07 |
Pharmaxis Ltd. |
Improvements relating to delivery devices
|
DK2731571T3
(da)
*
|
2011-07-13 |
2020-02-17 |
Pharmaxis Ltd |
Forbedringer vedrørende leveringsanordninger
|
SG11201404640YA
(en)
|
2012-02-10 |
2014-09-26 |
Virun Inc |
Beverage compositions containing non-polar compounds
|
US10525216B2
(en)
|
2012-02-21 |
2020-01-07 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
SG11201408411VA
(en)
|
2012-07-05 |
2015-01-29 |
Glaxo Group Ltd |
Inhaler device
|
UA111442C2
(uk)
*
|
2012-10-02 |
2016-04-25 |
Кмс Ді Колозіо Мауро |
Інгаляційний пристрій
|
US9764103B2
(en)
*
|
2012-10-05 |
2017-09-19 |
Lily A. Neff |
Salt puffer
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
EP2991713B1
(en)
|
2013-04-28 |
2019-06-19 |
Impel Neuropharma Inc. |
Medical unit dose container
|
WO2014178891A1
(en)
|
2013-04-30 |
2014-11-06 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
WO2015017728A1
(en)
|
2013-07-31 |
2015-02-05 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
WO2015106150A1
(en)
|
2014-01-10 |
2015-07-16 |
Genoa Pharmaceuticals Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
WO2015127315A1
(en)
|
2014-02-20 |
2015-08-27 |
Otitopic Inc. |
Dry powder formulations for inhalation
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
ES2841933T3
(es)
|
2014-10-31 |
2021-07-12 |
Univ Monash |
Formulación en polvo
|
WO2016130800A2
(en)
|
2015-02-12 |
2016-08-18 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
US11266799B2
(en)
|
2015-09-10 |
2022-03-08 |
Impel Neuropharma, Inc. |
In-line nasal delivery device
|
BR112018009899A8
(pt)
|
2015-11-18 |
2019-02-26 |
Glaxosmithkline Ip No 2 Ltd |
composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose.
|
IT201600095707A1
(it)
*
|
2016-09-23 |
2018-03-23 |
Cms Di Colosio Mauro |
Dispositivo inalatore
|
IT201600095634A1
(it)
*
|
2016-09-23 |
2018-03-23 |
Cms Di Colosio Mauro |
Dispositivo inalatore
|
US10858305B2
(en)
|
2016-11-30 |
2020-12-08 |
Neonc Technologies, Inc. |
Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
|
US9731103B1
(en)
|
2017-01-13 |
2017-08-15 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration devices and associated systems and methods
|
RU170809U1
(ru)
*
|
2017-03-01 |
2017-05-11 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Нижегородский государственный технический университет им. Р.Е. Алексеева" (НГТУ) |
Распылитель порошкообразных материалов со сменной насадкой
|
WO2018174938A1
(en)
|
2017-03-23 |
2018-09-27 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
US10792226B2
(en)
|
2017-06-07 |
2020-10-06 |
Berkshire Biomedical, LLC |
Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
|
JP2021503988A
(ja)
|
2017-11-21 |
2021-02-15 |
インペル ニューロファーマ インコーポレイテッド |
インレットインターフェースを用いた鼻腔内装置
|
WO2019104205A1
(en)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Intranasal device with dip tube
|
BR112020013744A8
(pt)
|
2018-01-05 |
2022-10-18 |
Impel Neuropharma Inc |
Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão
|
WO2019136308A1
(en)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
US20210228498A1
(en)
|
2018-02-08 |
2021-07-29 |
Neonc Technologies, Inc. |
Methods of permeabilizing the blood brain barrier
|
US10441509B2
(en)
|
2018-03-16 |
2019-10-15 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
|
WO2020018959A1
(en)
|
2018-07-19 |
2020-01-23 |
Impel Neuropharma, Inc. |
Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
|
BR112021013244A8
(pt)
|
2019-01-03 |
2022-10-18 |
Impel Neuropharma Inc |
Dispositivo de entrega de fármaco nasal
|
JP2022547365A
(ja)
|
2019-03-14 |
2022-11-14 |
オーエム ファーマ エスエー |
喘息、喘息悪化、アレルギー性喘息及び/又は関連疾患状態を呼吸器疾患に関連する微生物叢で治療及び/又は予防する方法
|
EP4234026A2
(en)
|
2019-03-14 |
2023-08-30 |
OM Pharma SA |
Process for making stable bacterial extracts and their use as pharmaceuticals
|
JP2022532259A
(ja)
|
2019-05-17 |
2022-07-13 |
インペル ファーマシューティカルズ インコーポレイテッド |
使い捨ての鼻腔内送達デバイス
|
US10729860B1
(en)
|
2019-05-22 |
2020-08-04 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration for securely dispensing a medication and associated systems and methods
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
WO2023205389A1
(en)
|
2022-04-22 |
2023-10-26 |
Quench Medical Inc. |
Dry powder inhalation delivery of pharmaceuticals
|
WO2023232976A1
(en)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
|